• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Tri-modality Therapy in Esophageal Carcinoma is at a Crossroad.

作者信息

Vashist Yogesh K, Shukla Srijan, Abufarhaneh Ehab, Broering Dieter C, Subramanyeshwar Rao Thammineedi

机构信息

Organ Transplant Center of Excellence, King Faisal Specialist Hospital and Research Center, Riyadh, Kingdom of Saudi Arabia.

Department of Surgical Oncology, Basavatarakam Indo-American Cancer Hospital and Research Institute, Hyderabad, India.

出版信息

Ann Surg Oncol. 2025 Feb;32(2):643-645. doi: 10.1245/s10434-024-16499-9. Epub 2024 Nov 15.

DOI:10.1245/s10434-024-16499-9
PMID:39548052
Abstract
摘要

相似文献

1
Tri-modality Therapy in Esophageal Carcinoma is at a Crossroad.食管癌的三联疗法正处于十字路口。
Ann Surg Oncol. 2025 Feb;32(2):643-645. doi: 10.1245/s10434-024-16499-9. Epub 2024 Nov 15.
2
Tri-modality therapy in advanced esophageal carcinoma: Long-term results and insights from a developing world, institutional cohort.晚期食管癌的三联疗法：来自发展中国家一个机构队列的长期结果与见解
Br J Radiol. 2023 Jun;96(1146):20230150. doi: 10.1259/bjr.20230150. Epub 2023 Apr 22.
3
Patterns and predictors of failure following tri-modality therapy for locally advanced esophageal cancer.局部晚期食管癌三联疗法失败的模式及预测因素
Acta Oncol. 2016;55(3):303-8. doi: 10.3109/0284186X.2015.1110252. Epub 2015 Nov 19.
4
Multi-disciplinary management of esophageal carcinoma: Current practices and future directions.食管癌的多学科综合管理：现状与未来方向。
Crit Rev Oncol Hematol. 2024 May;197:104315. doi: 10.1016/j.critrevonc.2024.104315. Epub 2024 Mar 9.
5
Association of treatment factors with surgical outcomes in tri-modality therapy for esophageal cancer.食管癌三联疗法中治疗因素与手术结果的关联
J Surg Oncol. 2015 Nov;112(6):629-33. doi: 10.1002/jso.24060. Epub 2015 Oct 2.
6
Circulating tumor cells detected in follow-up predict survival outcomes in tri-modality management of advanced non-metastatic esophageal cancer: a secondary analysis of the QUINTETT randomized trial.随访中检测到的循环肿瘤细胞可预测晚期非转移性食管癌三联治疗的生存结局：QUINTETT 随机试验的二次分析。
BMC Cancer. 2022 Jul 8;22(1):746. doi: 10.1186/s12885-022-09846-0.
7
Combining the radiomic features and traditional parameters of F-FDG PET with clinical profiles to improve prognostic stratification in patients with esophageal squamous cell carcinoma treated with neoadjuvant chemoradiotherapy and surgery.将 F-FDG PET 的放射组学特征和传统参数与临床特征相结合，以改善接受新辅助放化疗和手术治疗的食管鳞癌患者的预后分层。
Ann Nucl Med. 2019 Sep;33(9):657-670. doi: 10.1007/s12149-019-01380-7. Epub 2019 Jun 19.
8
Comparative study of the N-linked oligosaccharides released from normal human esophageal epithelium and esophageal squamous carcinoma.正常人食管上皮和食管鳞状细胞癌释放的N-连接寡糖的比较研究。
Jpn J Cancer Res. 1990 Apr;81(4):363-71. doi: 10.1111/j.1349-7006.1990.tb02576.x.
9
Bi-modality (chemo-radiation) versus tri-modality (chemo-radiation followed by surgery) treatment for carcinoma of the esophagus.食管癌的双模式（化疗-放疗）与三模式（化疗-放疗后手术）治疗
Dis Esophagus. 2001;14(3-4):202-7. doi: 10.1046/j.1442-2050.2001.00185.x.
10
A tantalum oxide-based core/shell nanoparticle for triple-modality image-guided chemo-thermal synergetic therapy of esophageal carcinoma.基于氧化钽的核壳纳米粒子用于食管癌的多模态影像引导化疗-热协同治疗。
Cancer Lett. 2017 Jul 1;397:61-71. doi: 10.1016/j.canlet.2017.03.030. Epub 2017 Mar 27.

本文引用的文献

1
Recurrence Patterns and Long-Term Results After Curative Surgery for Patients With Breast Cancer.乳腺癌患者根治性手术后的复发模式及长期结果
Ann Surg Oncol. 2025 Apr;32(4):2554-2568. doi: 10.1245/s10434-024-16726-3. Epub 2024 Dec 30.
2
Prognostic Factors of Long-Term Survival and Conditional Survival Analysis in MPM Patients Treated with CRS+HIPEC: A Retrospective Study of Two Centers.接受CRS+HIPEC治疗的MPM患者长期生存的预后因素及条件生存分析：一项对两个中心的回顾性研究
Ann Surg Oncol. 2025 Apr;32(4):2912-2922. doi: 10.1245/s10434-024-16485-1. Epub 2024 Nov 13.
3
Oncological outcomes of standard versus prolonged time to surgery after neoadjuvant chemoradiotherapy for oesophageal cancer in the multicentre, randomised, controlled NeoRes II trial.
新辅助放化疗后标准手术时间与延长手术时间治疗食管癌的多中心随机对照 NeoRes II 试验的肿瘤学结果。
Ann Oncol. 2023 Nov;34(11):1015-1024. doi: 10.1016/j.annonc.2023.08.010. Epub 2023 Aug 30.
4
Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy followed by minimally invasive esophagectomy for locally advanced esophageal squamous cell carcinoma: a prospective multicenter randomized clinical trial.新辅助放化疗对比新辅助化疗后行微创食管切除术治疗局部进展期食管鳞癌：一项前瞻性多中心随机临床试验。
Ann Oncol. 2023 Feb;34(2):163-172. doi: 10.1016/j.annonc.2022.10.508. Epub 2022 Nov 15.
5
Factors associated with pathologic complete response following neoadjuvant chemoradiation and esophagectomy for carcinoma of esophagus and gastroesophageal junction.新辅助放化疗和食管胃交界部癌切除术治疗后病理完全缓解的相关因素。
J Surg Oncol. 2023 Jan;127(1):48-55. doi: 10.1002/jso.27103. Epub 2022 Sep 21.
6
Pathological complete response after neoadjuvant treatment determines survival in esophageal squamous cell carcinoma patients (NEOCRTEC5010).新辅助治疗后的病理完全缓解决定食管鳞状细胞癌患者的生存情况（NEOCRTEC5010）。
Ann Transl Med. 2021 Oct;9(20):1516. doi: 10.21037/atm-21-3331.
7
Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer.纳武利尤单抗辅助治疗食管或胃食管结合部癌。
N Engl J Med. 2021 Apr 1;384(13):1191-1203. doi: 10.1056/NEJMoa2032125.
8
A randomized clinical trial of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the oesophagus or gastro-oesophageal junction.一项关于新辅助化疗与新辅助放化疗治疗食管癌或胃食管交界癌的随机临床试验。
Ann Oncol. 2016 Apr;27(4):660-7. doi: 10.1093/annonc/mdw010. Epub 2016 Jan 17.
9
Salvage Surgery After Chemoradiotherapy in the Management of Esophageal Cancer: Is It a Viable Therapeutic Option?放化疗后挽救性手术治疗食管癌：是否可行的治疗选择？
J Clin Oncol. 2015 Nov 20;33(33):3866-73. doi: 10.1200/JCO.2014.59.9092. Epub 2015 Jul 20.
10
Patterns of recurrence after surgery alone versus preoperative chemoradiotherapy and surgery in the CROSS trials.CROSS 试验中单手术治疗与术前放化疗加手术治疗后的复发模式。
J Clin Oncol. 2014 Feb 10;32(5):385-91. doi: 10.1200/JCO.2013.51.2186. Epub 2014 Jan 13.